高效液相色谱法测定血液透析患者缬沙坦血药浓度

R459.5; 目的 探讨血液透析对缬沙坦血药浓度的影响.方法 收集2018年1月至2022年1月于北京中医药大学厦门医院门诊就诊及住院的55例血液透析患者相关资料,受试者在血液透析前6 h服用缬沙坦胶囊80 mg,采集透析开始时及透析结束时透析器中静脉血,采用高效液相色谱法测定血药浓度.结果 缬沙坦低、中、高浓度的回收率分别为(100.75±1.36)%、(103.12±1.02)%、(101.68±2.37)%,相对标准偏差分别为1.35%、0.99%、2.33%.透析后缬沙坦血药浓度(0.47 μg/mL)低于透析前(0.67 μg/mL),差异有统计学意义(P<0.01).患者年龄、血...

Full description

Saved in:
Bibliographic Details
Published in现代医药卫生 Vol. 40; no. 22; pp. 3781 - 3785
Main Authors 王海烨, 许正锦, 赖源发, 郑凤伟, 陈慧, 许勇镇, 吴玲艳, 蔡丽娜, 文娱
Format Journal Article
LanguageChinese
Published 北京中医药大学厦门医院,福建厦门 361009%厦门华夏学院,福建厦门 361024 2024
Subjects
Online AccessGet full text
ISSN1009-5519
DOI10.3969/j.issn.1009-5519.2024.22.001

Cover

Loading…
Abstract R459.5; 目的 探讨血液透析对缬沙坦血药浓度的影响.方法 收集2018年1月至2022年1月于北京中医药大学厦门医院门诊就诊及住院的55例血液透析患者相关资料,受试者在血液透析前6 h服用缬沙坦胶囊80 mg,采集透析开始时及透析结束时透析器中静脉血,采用高效液相色谱法测定血药浓度.结果 缬沙坦低、中、高浓度的回收率分别为(100.75±1.36)%、(103.12±1.02)%、(101.68±2.37)%,相对标准偏差分别为1.35%、0.99%、2.33%.透析后缬沙坦血药浓度(0.47 μg/mL)低于透析前(0.67 μg/mL),差异有统计学意义(P<0.01).患者年龄、血浆白蛋白、尿素氮、血肌酐与血药浓度均无相关性(P>0.01).结论 缬沙坦在血液透析后血药浓度呈下降趋势.
AbstractList R459.5; 目的 探讨血液透析对缬沙坦血药浓度的影响.方法 收集2018年1月至2022年1月于北京中医药大学厦门医院门诊就诊及住院的55例血液透析患者相关资料,受试者在血液透析前6 h服用缬沙坦胶囊80 mg,采集透析开始时及透析结束时透析器中静脉血,采用高效液相色谱法测定血药浓度.结果 缬沙坦低、中、高浓度的回收率分别为(100.75±1.36)%、(103.12±1.02)%、(101.68±2.37)%,相对标准偏差分别为1.35%、0.99%、2.33%.透析后缬沙坦血药浓度(0.47 μg/mL)低于透析前(0.67 μg/mL),差异有统计学意义(P<0.01).患者年龄、血浆白蛋白、尿素氮、血肌酐与血药浓度均无相关性(P>0.01).结论 缬沙坦在血液透析后血药浓度呈下降趋势.
Abstract_FL Objective To investigate the effect of hemodialysis on plasma concentration of valsartan.Methods The relevant data of 55 hemodialysis patients in Xiamen Hospital Affiliated to Beijing University of Traditional Chinese Medicine from January 2018 to January 2022 were collected.The subjects took 80 mg of valsartan capsule 6 hours before hemodialysis,and the venous blood was collected from the dialyzer at the be-ginning and end of dialysis,and the plasma concentration was determined by high performance liquid chroma-tography.Results The recovery rates of valsartan at low,medium and high concentrations were(100.75±1.36)%,(103.12±1.02)%and(101.68±2.37)%,respectively,and the relative standard deviation were 1.35%,0.99%and 2.33%,respectively.The plasma concentration of valsartan after dialysis(0.47 μg/mL)was lower than that before dialysis(0.67 μg/mL),the difference was statistically significant(P<0.01).There was no correlation between age,plasma albumin,urea nitrogen,serum creatinine and plasma concentration(P>0.01).Conclusion The plasma concentration of valsartan shows a downward trend after hemodialysis.
Author 许正锦
王海烨
郑凤伟
文娱
赖源发
陈慧
蔡丽娜
许勇镇
吴玲艳
AuthorAffiliation 北京中医药大学厦门医院,福建厦门 361009%厦门华夏学院,福建厦门 361024
AuthorAffiliation_xml – name: 北京中医药大学厦门医院,福建厦门 361009%厦门华夏学院,福建厦门 361024
Author_FL CHEN Hui
XU Zhengjin
WU Lingyan
LAI Yuanfa
WANG Haihua
CAI Lina
WEN Yu
XU Yongzhen
ZHENG Fengwei
Author_FL_xml – sequence: 1
  fullname: WANG Haihua
– sequence: 2
  fullname: XU Zhengjin
– sequence: 3
  fullname: LAI Yuanfa
– sequence: 4
  fullname: ZHENG Fengwei
– sequence: 5
  fullname: CHEN Hui
– sequence: 6
  fullname: XU Yongzhen
– sequence: 7
  fullname: WU Lingyan
– sequence: 8
  fullname: CAI Lina
– sequence: 9
  fullname: WEN Yu
Author_xml – sequence: 1
  fullname: 王海烨
– sequence: 2
  fullname: 许正锦
– sequence: 3
  fullname: 赖源发
– sequence: 4
  fullname: 郑凤伟
– sequence: 5
  fullname: 陈慧
– sequence: 6
  fullname: 许勇镇
– sequence: 7
  fullname: 吴玲艳
– sequence: 8
  fullname: 蔡丽娜
– sequence: 9
  fullname: 文娱
BookMark eNrjYmDJy89LZWBQMTTQM7Y0s9TP0sssLs7TMzQwsNQ1NTW01DMyMDLRMzLSMzAwZGHghItzMPAWF2cmGZgaGpubGJkbcjI4vVw949nUjmfbNj2fveNF56YXGzY-2zz12dbup-tmvVjYABR_2dD_bN6EZ02LXzS0Pt-z5tmmmU_nLgNKvehd_2zr5Ke7lvEwsKYl5hSn8kJpbgZ1N9cQZw_d8sS8tMS89Pis_NKiPKBMfEVKZWV5MchtRkZAlxkTrxIAZjNeRg
ClassificationCodes R459.5
ContentType Journal Article
Copyright Copyright © Wanfang Data Co. Ltd. All Rights Reserved.
Copyright_xml – notice: Copyright © Wanfang Data Co. Ltd. All Rights Reserved.
DBID 2B.
4A8
92I
93N
PSX
TCJ
DOI 10.3969/j.issn.1009-5519.2024.22.001
DatabaseName Wanfang Data Journals - Hong Kong
WANFANG Data Centre
Wanfang Data Journals
万方数据期刊 - 香港版
China Online Journals (COJ)
China Online Journals (COJ)
DatabaseTitleList
DeliveryMethod fulltext_linktorsrc
DocumentTitle_FL Determination of valsartan plasma concentration in hemodialysis patients by high performance liquid chromatography
EndPage 3785
ExternalDocumentID xdyyws202422001
GrantInformation_xml – fundername: 福建省卫生厅青年科研课题资助项目
  funderid: (2017-2-103)
GroupedDBID -05
-0E
-SE
-S~
.5D
2B.
2RA
4A8
5SA
5VR
92F
92I
92L
92M
93N
9D9
9DE
AAITT
ABDBF
ABJNI
ACGFS
ACUHS
AFUIB
ALMA_UNASSIGNED_HOLDINGS
CAJEE
CCEZO
CIEJG
CQIGP
CW7
CW9
EOJEC
ESX
FA0
J.9
JUIAU
M~T
OBODZ
PB1
PB7
PSX
Q--
Q-4
R-E
RT5
S..
T8U
TCJ
TGQ
U1F
U1G
U5E
U5O
W91
WFFXF
~WA
ID FETCH-wanfang_journals_xdyyws2024220013
ISSN 1009-5519
IngestDate Thu May 29 03:59:13 EDT 2025
IsPeerReviewed false
IsScholarly true
Issue 22
Keywords Hypertension
End-stage renal disease
缬沙坦
Valsartan
高血压
Hemodialysis
高效液相色谱
血液透析
High performance liquid chromatography
终末期肾病
Language Chinese
LinkModel OpenURL
MergedId FETCHMERGED-wanfang_journals_xdyyws2024220013
ParticipantIDs wanfang_journals_xdyyws202422001
PublicationCentury 2000
PublicationDate 2024
PublicationDateYYYYMMDD 2024-01-01
PublicationDate_xml – year: 2024
  text: 2024
PublicationDecade 2020
PublicationTitle 现代医药卫生
PublicationTitle_FL Journal of Modern Medicine & Health
PublicationYear 2024
Publisher 北京中医药大学厦门医院,福建厦门 361009%厦门华夏学院,福建厦门 361024
Publisher_xml – name: 北京中医药大学厦门医院,福建厦门 361009%厦门华夏学院,福建厦门 361024
SSID ssib051374271
ssj0002402475
Score 4.6814303
Snippet R459.5; 目的 探讨血液透析对缬沙坦血药浓度的影响.方法 收集2018年1月至2022年1月于北京中医药大学厦门医院门诊就诊及住院的55例血液透析患者相关资料,受试者在血液透析前6 h服用缬沙坦胶囊80 mg,采集透析开始时及透析结束时透析器中静脉血,采用高效液相色谱法测定血药浓度.结果...
SourceID wanfang
SourceType Aggregation Database
StartPage 3781
Title 高效液相色谱法测定血液透析患者缬沙坦血药浓度
URI https://d.wanfangdata.com.cn/periodical/xdyyws202422001
Volume 40
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3daxNBEF9qCuKLKH5_kYcuPkhi73vncTe5UAR9qtC3kqQ5fYrQpmj7FARBEVGQgh8oiNAXxY9IRcR_J9f0v3Bmbps7NFothGNudvY3M7vszdze7kaImSZ0klYS0qxNFFR8CKECbcevBLNtgE44m0RAm5OvXgvnrvtXFoKFqdLJwqql1V6r2l6fuK9kP72KPOxX2iX7Hz07BkUG0ti_eMUexus_9bGMQWojQck4lBBIxYTBnyvjSIKRBjlKKmCOkmZWGodlPJInAmsZGQdSxxI0yWiHVj_kOEC3qsEqUIaLlCu1x8hYFJAuU5O6xrVcCUCAUJc6LACiMHIaVil4JGM0yhTzY4JSMdkZ-9IY1oIW1ojOEQImDPvoSxgvTra1ySFWYiLmeFKrXESRq4ZbStdZARCKDosiZGHIKJpdDqgFwMlFgGDB4ZJIap_tre3aYqdR3HwC1boBEQtqbiyfzEAbJnqIkDpiImvHgDwjAghEq0ItoBbXLo4WchdlFCNgESr6reIlD3NZOv81-ANonZiZBRmQtWAfamwDZEGPPpBh5gzFqJgdomVHf7Z13MY4L8r-ZMfmS3gbTIrFHo57jsWkozrWUaXGr7p0TK6T5yDjlaF3ltbWbq-QjEur_Q6IaTeKHAxX09rUTWM3VASOF_mufZOhpIs-Evp8rPZY00ExY824_DcjeLdeN2l2bxQSy_kj4rB9IyzrbHgfFVPrN48Js_PuWbpxP_062H75bfRgMPr0Of2ykW49HH54MXrTR_5O_3H6-kl69-2of2_7x_t08Hz4ahOLRo8-pltPh983j4uLjXi-NlexehftI2Vl8RfvvROi1L3V7ZwSZcf3aeqxlTS9lu8qUAm0wxa-zYTNduQtuadFeS-0M3uLnBWHiM6mGM-JUm95tXMek-5e64LtgJ9X9J7n
linkProvider EBSCOhost
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=%E9%AB%98%E6%95%88%E6%B6%B2%E7%9B%B8%E8%89%B2%E8%B0%B1%E6%B3%95%E6%B5%8B%E5%AE%9A%E8%A1%80%E6%B6%B2%E9%80%8F%E6%9E%90%E6%82%A3%E8%80%85%E7%BC%AC%E6%B2%99%E5%9D%A6%E8%A1%80%E8%8D%AF%E6%B5%93%E5%BA%A6&rft.jtitle=%E7%8E%B0%E4%BB%A3%E5%8C%BB%E8%8D%AF%E5%8D%AB%E7%94%9F&rft.au=%E7%8E%8B%E6%B5%B7%E7%83%A8&rft.au=%E8%AE%B8%E6%AD%A3%E9%94%A6&rft.au=%E8%B5%96%E6%BA%90%E5%8F%91&rft.au=%E9%83%91%E5%87%A4%E4%BC%9F&rft.date=2024&rft.pub=%E5%8C%97%E4%BA%AC%E4%B8%AD%E5%8C%BB%E8%8D%AF%E5%A4%A7%E5%AD%A6%E5%8E%A6%E9%97%A8%E5%8C%BB%E9%99%A2%2C%E7%A6%8F%E5%BB%BA%E5%8E%A6%E9%97%A8+361009%25%E5%8E%A6%E9%97%A8%E5%8D%8E%E5%A4%8F%E5%AD%A6%E9%99%A2%2C%E7%A6%8F%E5%BB%BA%E5%8E%A6%E9%97%A8+361024&rft.issn=1009-5519&rft.volume=40&rft.issue=22&rft.spage=3781&rft.epage=3785&rft_id=info:doi/10.3969%2Fj.issn.1009-5519.2024.22.001&rft.externalDocID=xdyyws202422001
thumbnail_s http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fwww.wanfangdata.com.cn%2Fimages%2FPeriodicalImages%2Fxdyyws%2Fxdyyws.jpg